Valuation : Burning Rock Biotech Limited

Market Cap 649M 96.5M 83.25M 78.42M 71.45M 134M 9.12B 135M 928M 360M 4.66B 362M 354M 15.31B P/E 2024
-1.46x
P/E 2025 -27.1x
Enterprise Value 211M 31.38M 27.07M 25.5M 23.23M 43.42M 2.96B 43.75M 302M 117M 1.52B 118M 115M 4.98B EV / Sales 2024
0.06x
EV / Sales 2025 2x
Free-Float
61.34%
Yield 2024 *
-
Yield 2025 -
1 day+6.01%
1 week-3.00%
Current month+2.65%
1 month+9.73%
3 months+11.62%
6 months-58.79%
Current year-51.86%
1 week 9.15
Extreme 9.15
10.42
1 month 8.81
Extreme 8.81
11.27
Current year 6.79
Extreme 6.79
41.72
1 year 6.79
Extreme 6.79
41.72
3 years 2.18
Extreme 2.18
41.72
5 years 2.18
Extreme 2.18
213.65
10 years 2.18
Extreme 2.18
397.5
Manager TitleAgeSince
Corporate Officer/Principal - 01/01/2014
Chief Executive Officer 48 01/01/2014
Director of Finance/CFO - 27/09/2024
Director TitleAgeSince
Chairman 48 -
Director/Board Member 55 01/06/2014
Director/Board Member 63 01/08/2016
Date Insider Type Main position Quantity % Market Cap. Importance
31/3/26 Buy

Chief Executive Officer

314,870 0.3584%
18/3/26
Northern Light Venture Capital Development Ltd.
OtherCompany 11,880,245 13.5213%
17/3/26 Other

Director

22,718 0.0259%
Change 5-day change 1-year change 3-year change Capi.($)
+6.01%-3.00%+22.01%-23.62% 96.5M
-1.05%-5.35%+91.36%+439.44% 46.87B
+0.74%-0.83%+21.88%+63.25% 26.9B
+3.04%-3.79%-18.74%-40.06% 6.64B
-2.11%-2.38%+3.69%+136.26% 5.96B
+0.47%-0.58%+15.36%+77.39% 3.39B
-0.12%-3.41%-32.24%+1,872.54% 2.59B
-0.83%-7.89%+109.65%+21.00% 2.24B
+6.69%+6.35%+29.42%+35.03% 2.09B
-2.60%-5.64%-13.69%-55.31% 1.83B
Average +1.03%-2.74%+22.87%+252.59% 9.86B
Weighted average by Cap. -0.13%-3.23%+50.92%+283.63%

Financials

2024 2025
Net sales 516M 76.75M 66.21M 62.38M 56.83M 106M 7.25B 107M 738M 287M 3.71B 288M 282M 12.18B 540M 80.29M 69.26M 65.25M 59.45M 111M 7.58B 112M 772M 300M 3.88B 301M 295M 12.74B
Net income -347M -51.58M -44.5M -41.92M -38.19M -71.38M -4.87B -71.92M -496M -193M -2.49B -194M -189M -8.18B -55.35M -8.24M -7.1M -6.69M -6.1M -11.4M -778M -11.48M -79.23M -30.75M -398M -30.92M -30.25M -1.31B
Net Debt -474M -70.48M -60.8M -57.28M -52.19M -97.54M -6.66B -98.28M -678M -263M -3.4B -265M -259M -11.18B -438M -65.12M -56.18M -52.92M -48.22M -90.13M -6.15B -90.81M -627M -243M -3.15B -245M -239M -10.33B
Logo Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Employees
-
Date Price Change Volume
03/09/26 US$9.700 +6.01% 113,135
02/09/26 US$9.150 -0.76% 3,621
01/09/26 US$9.220 -2.43% 3,403
31/08/26 US$9.450 -7.26% 5,704
28/08/26 US$10.19 +1.90% 29,177